novo glp 1 drugs Novo, Lilly weight-loss should be first option obesity treatments, European doctors say The weight loss drug boom

It stimulates the GLP-1 receptor in the brain, making you feel full

In these instances, we work on lifestyle modification and collaborate with our endobariatric colleagues to provide the latest minimally invasive techniques for managing weight regain, while also using medications like GLP-1 receptor agonists to help people achieve the healthiest weight possible

References Shirley M

Ischemic Optic Neuropathy with Semaglutide: Global Observational Analysis of Sex- and Formulation-Specific Risk. The British Journal of Ophthalmology , Mar

Although tirzepatide still outperforms semaglutide on average

As a result, the FDA granted an additional indication for Wegovy to reduce the risk of major cardiovascular events in March 2024